Evidence map›Paper›PMID 41467120›Full record

ArticleMolecular therapy. Nucleic acids2025

Behavioral improvement in dystrophic

Artadokht Aghaeipour, Manuela Mitsogiannis, Claire Fergus, Konstantina Tetorou, Talia Gileadi, Erwina Stojek, Silvia Talavera, Simran Singh, Matthew Siddle, Jack Prendeville and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Artadokht AghaeipourThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Manuela MitsogiannisTranspharmation Ireland Ltd., Trinity College Institute of Neuroscience, Trinity College Dublin, D02 PX31 Dublin, Ireland.
Claire FergusSchool of Biochemistry & Immunology, Trinity College Dublin, D02 R590 Dublin, Ireland.
Konstantina TetorouThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Talia GileadiThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Erwina StojekTranspharmation Ireland Ltd., Trinity College Institute of Neuroscience, Trinity College Dublin, D02 PX31 Dublin, Ireland.
Silvia TalaveraTranspharmation Ireland Ltd., Trinity College Institute of Neuroscience, Trinity College Dublin, D02 PX31 Dublin, Ireland.
Simran SinghThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Matthew SiddleThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Jack PrendevilleTranspharmation Ireland Ltd., Trinity College Institute of Neuroscience, Trinity College Dublin, D02 PX31 Dublin, Ireland.
Ewa SokolowskaTranspharmation Poland Sp. z o.o., University of Warmia & Mazury in Olsztyn, 10-719 Olsztyn, Poland.
Vincent KellySchool of Biochemistry & Immunology, Trinity College Dublin, D02 R590 Dublin, Ireland.
Jennifer MorganThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Federica MontanaroThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.
Francesco MuntoniThe Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, WC1N 1EH London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the

Indexed as

antisense oligonucleotidebehaviour studiesbrain comorbiditiesbrain dystrophinDuchenne muscular dystrophyDystrophinExon skippingMT: Oligonucleotides: therapies and applicationsneuromuscular disease

Identifiers

PMID41467120
PMCPMC12744854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.